Showing 1 - 20 results of 37,424 for search '(( has been decrease ) OR ((( a large decrease ) OR ( _ ((_ decrease) OR (linear decrease)) ))))', query time: 0.55s Refine Results
  1. 1

    <b>Supporting data for manuscript</b> "<b>Voluntary locomotion induces an early and remote hemodynamic decrease in the large cerebral veins</b>" by Kira Shaw (18796168)

    Published 2025
    “…These time series traces are 2-dimensional with dimension 1 (rows) representing the individual locomotion events which the data has been cut around, and dimension 2 (length) representing the number of frames captured (200 frames, recording speed 7.9932 frames per second). …”
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Why does task performance decrease with burst length? by Swathi Anil (17382903)

    Published 2025
    “…<p>Explanation of why accuracy decreases for methods that do not use temporal information (<i>LF</i>, <i>NLF</i>) as <i>k</i> increases. …”
  7. 7
  8. 8

    Decrease in Total Cholesterol level based on Salt Intake. by Giti Azim (20940548)

    Published 2025
    “…<p>Level of total cholesterol decreasing based on salt intake.</p>…”
  9. 9

    Decrease in Blood Glucose level based on Education Level. by Giti Azim (20940548)

    Published 2025
    “…<p>Level of total cholesterol decreasing based on salt intake.</p>…”
  10. 10
  11. 11

    ECoG timescales decrease during spatial attention. by Isabel Raposo (21615517)

    Published 2025
    “…Bottom: timescales significantly decrease during covert attention relative to the attend-out condition (two locations: <i>p</i> = 0.0244; four locations: <i>p</i> < 0.0001; mean ± SEM; whiskers indicate maximum and minimum; dots correspond to individual electrodes). …”
  12. 12
  13. 13
  14. 14
  15. 15

    Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. …”
  16. 16

    Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. …”
  17. 17

    Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…Ruxolitinib, a JAK/STAT inhibitor, has been shown to improve cutaneous manifestations of SLE. …”
  18. 18
  19. 19
  20. 20